Evidence map›Paper›PMID 35681060›Full record

ReviewNature reviews. Genetics2022

tRNA dysregulation and disease.

Esteban A Orellana, Elisabeth Siegal, Richard I Gregory

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 166 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Hypertensive mt. tRNARedox biology · 2026
    Article
  6. Article
  7. Article
  8. Thermophysical Properties of a tRNA Isodecoder.The journal of physical chemistry. B · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. A class of deep intronicmedRxiv : the preprint server for health sciences · 2026
    Article
  17. The regulation, function and disease relevance of cytoplasmic tRNAs.Nature reviews. Molecular cell biology · 2026
    Review
  18. Review
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Esteban A OrellanaStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0003-4369-9416
Elisabeth SiegalStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Richard I GregoryStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. rgregory@enders.tch.harvard.edu.ORCID 0000-0001-8090-8673
Boston Children's Hospital · US

Funding

Role of the Epitranscriptome in CancerR35CA232115 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREGORY, RICHARD I. · 2019 to 2025
$7.2M
NCI NIH HHS R35 CA232115
6 · The paper itself

Abstract

tRNAs are key adaptor molecules that decipher the genetic code during translation of mRNAs in protein synthesis. In contrast to the traditional view of tRNAs as ubiquitously expressed housekeeping molecules, awareness is now growing that tRNA-encoding genes display tissue-specific and cell type-specific patterns of expression, and that tRNA gene expression and function are both dynamically regulated by post-transcriptional RNA modifications. Moreover, dysregulation of tRNAs, mediated by alterations in either their abundance or function, can have deleterious consequences that contribute to several distinct human diseases, including neurological disorders and cancer. Accumulating evidence shows that reprogramming of mRNA translation through altered tRNA activity can drive pathological processes in a codon-dependent manner. This Review considers the emerging evidence in support of the precise control of functional tRNA levels as an important regulatory mechanism that coordinates mRNA translation and protein expression in physiological cell homeostasis, and highlights key examples of human diseases that are linked directly to tRNA dysregulation.

Indexed as

RNA Processing, Post-TranscriptionalRNA, TransferCodonHumansProtein BiosynthesisProteomicsRNA, MessengerCodonRNA, MessengerRNA, Transfer

Identifiers

PMID35681060
PMCPMC11170316
OpenAlexW4282914538

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.